Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetesTHE WOODLANDS, Texas, June ...

Lexicon Pharmaceuticals announced that it will present data from a study on sotagliflozin's effects on hypoglycemia in individuals with type 1 diabetes at the upcoming American Diabetes ...

Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a ...

THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 ...

InvestingPro’s Fair Value analysis has once again demonstrated its effectiveness in identifying undervalued opportunities, with Lexicon Pharmaceuticals (NASDAQ:LXRX) delivering a remarkable 67% ...

InvestingPro’s Fair Value analysis has once again demonstrated its effectiveness in identifying undervalued opportunities, with Lexicon Pharmaceuticals (NASDAQ:LXRX) delivering a remarkable 67% return ...

THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies ...

Industry watchers responded mostly positively to the commissioner’s new voucher program, but worries remain over staffing cuts at the agency.